Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
Clinical trial NCT07079475 · RECRUITING
Trial details
- NCT number
- NCT07079475
- Sponsor
- Dizal (Jiangsu) Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2028-06-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.